Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring System
NCT: NCT07725445 · COMPLETED
Brief Summary
This study aims to evaluate the clinical applicability of the AI-based lightweight ECG monitoring system (MEMO Patch Plus) as a telemetry ECG monitoring system in patients undergoing cardiac surgery. Participants will wear the MEMO Patch Plus for at least 48 hours and up to 168 hours after transfer from the intensive care unit to the general ward. The study will evaluate real-time ECG transmission, arrhythmia detection, device usability, and safety to generate preliminary evidence supporting future clinical studies.
Frequently Asked Questions
What is Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring System?
Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring System is a clinical trial registered under NCT07725445. Current status: COMPLETED.
What is the status of NCT07725445?
The current status of NCT07725445 (Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring System) is: COMPLETED.
When did Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring System start?
Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring System started on 2022-09-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.